Varicella zoster virus (VZV) is a ubiquitous, human alphaherpesvirus that produces varicella on primary infection then becomes latent in ganglionic neurons along the entire neuraxis. In elderly and immunocompromised individuals, VZV reactivates and travels along nerve fibers peripherally resulting in zoster. However, VZV can also spread centrally and infect cerebral and extracranial arteries (VZV vasculopathy) to produce transient ischemic attacks, stroke, aneurysm, sinus thrombosis and giant cell arteritis, as well as granulomatous aortitis. The mechanisms of virus-induced pathological vascular remodeling are not fully elucidated; however, recent studies suggest that inflammation and dysregulation of programmed death ligand-1 play a significant role.
Introduction
Varicella zoster virus (VZV) is an exclusively human neurotropic alphaherpesvirus that infects N 95% of the U.S. population. Primary infection typically results in varicella (chickenpox), followed by establishment of virus latency in neurons of the cranial nerve, dorsal root and autonomic ganglia along the entire neuraxis, as well as of the adrenal glands (Badani et al., 2016) . With a decline in VZV-specific cellmediated immunity in elderly and immunocompromised individuals, defects in innate immunity (particularly NK cell defects; Levy et al.,
